pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-100 |
Genomic Coordinates | chr11: 122152229 - 122152308 |
Synonyms | MIRN100, miR-100, MIR100 |
Description | Homo sapiens miR-100 stem-loop |
Comment | This sequence is localised to chromosome 11 and was named mir-100-11 in reference . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-100-3p | |||||||||||||||||||||||||||
Sequence | 48| CAAGCUUGUAUCUAUAGGUAUG |69 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KATNAL1 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | katanin catalytic subunit A1 like 1 | ||||||||||||||||||||
Transcript | NM_001014380 | ||||||||||||||||||||
Other Transcripts | NM_032116 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KATNAL1 | |||||||||||||||||||||
3'UTR of KATNAL1 (miRNA target sites are highlighted) |
>KATNAL1|NM_001014380|3'UTR 1 ATTTCTGTCAGCTCTTTAATTTCTGGTATTTTTGTTGATAAAATACGAAGAAATTCCTGCAATTTTTAAAAAACAAGTTT 81 GGAATTTTTTTCAGTGGAGTGGTTTTCGCTTAAAGGAAAAAAAAATCTAAAACTGCGAAGAATACTAAATGTAGTTGAGA 161 AATAATTGATGGCGAGAGTTTGCTAGTCTCCCTCCCCGGCTTTGTGCTGGTATTCCACGTATTCCTGCATTAATATTGCA 241 CACCCAAACCAGTCTATCAGGGAGGCTGAAGCAAGGGCGCAGTGTGATATTTTAGGAATACAGAAGATTTAGAAATACCC 321 CTATTTCTCATTTGCAGTTTTTTTTTCCAATTCTGTGCTCTGTCAACATGAGGGACCTATCTATGTATGTTGACTTTTAA 401 CATCAAAATTGGATTTGTGTCAAACATTCATTGTTAAGAGAAGAATGACAGTATATTTTGGAGGAAATAATGAATTTACT 481 AATTAAACCTTTAGAATTTATGACTTACTGTTAGAGTCTGTCATATGGTTAGAATTTTTACTTCCGCTACCCCTGCCATT 561 TCTTCTGCTAGCTACTTCATAATATCTTGAGCTTTACTGAGGAATATTCTCACGCTCTGTGGTATTTGAATCATTTTGCC 641 AGGTCATTTCTCTGTCTTTAGTATTTTTTGCTGGTGCTTCTTACATTTAATATGGAAAGGTGGGAAGAATATTACTGCAT 721 TAGATGTAATTCTTCATTCTAGACTTCCAAGTTTGTTTTCACTTTTTTGTGTGTGCGTGAAGGAGTCTGTGTCACCCAGG 801 CTGTGTAGTGCAGTGGTTGATCTTGGCTCACTGCAACCTCTGCCTCCTAGATTCAAGCAATTCTCCTGTCTCAGCCTCCC 881 AAGTAGCTGGGATTACAGGTGCGCACCACCATGCCTGGCTGTGTTTTCACTTTTCTTTCAACATGTTCAACCAGATATAT 961 AGCCATTATTTTTCTCAGCTCCAGCATTGTTTGATTTTTCTTGAGTTTGATTTTAGTATTTGAGATAAATACTTTTACAT 1041 TCTAAACAAGTCCACTCTCTGTGGCTAACGCAAAACAAATGAAATCTTTATTGTTTTCCAAACAGCTAGTTTAACAAAAC 1121 AGCATCATACATAGTGAATGATGTTCATTGGAAAATTCTAAAATTTGTCCTTGTCTAGGTTGAGAACTTTTACACACACT 1201 AAGATAAAGATAGAAATCTGACATGCTCACTCAATTCAGCAGGAATTACACATTAGAAAGAAGCCAGAAAAATAAATGGC 1281 ATATATCCAATCACAAGTAAATGATCCTGGCGTTAGTTTTTATGATTACATGTGTCTCATTAGGCAATTTATGCTTTAAT 1361 GGTCAAGCTTTTAAAAATTTGTATTTGATAACATCCTGAATTCTCAGTTTCGAATAGTGCCTACTGGTTTAAAACTAAAA 1441 ATAATACAGCTTTTTGGACATTTAACCAAGATACTAAGAAGGTTTTTTTTAAAAAAAGAGATTTGATTATTTTTCCCTGC 1521 TAAAAACTGTAAATGCCTTATGTTCTTTTCAGATAACTTAAGTCTGACCTAAACTCCAGTATTCATCTGATGCTGTAAAT 1601 TGCCCTTCTTTCTGAGACACAGATTATAAGATGCCAGATCATAAGACATCATGATTTTATTGTAATTGAATTCTTCCTAA 1681 AAATTGAGAGGTTTCCTTTTATTAACTTTTAAAATAAAGAAATAAGTAGTTTCATTACGATTATTTTGCAAACTATTGCC 1761 AGTCAGAAATGCACTTTTTTTTTCCCTGAAGTTTTAGGAGCCGTCACTAAAACATTAGTCTTGTGATTGTTAAAACTTGT 1841 TTGTAATGGGTTGGTGCAAAAGTAATTGTGGTTTTTCCATTACTTTCAATGGCAAAAACCGCAATTACTTTTGCACCAGC 1921 CTAACAATAGTTGATTAGTTAGACCTTTTCTGGGTTTTGTATTGATTATCTTGGTGTGCATTTAATTATTTTTCTGAATT 2001 CTTCATGGATAATGACATAGTAATTGTGATTCTTTTAATACCAGTTAAGCAGTATTTGGCAACTTAAACTTCCTGGGAGC 2081 CTAACTTTACTATGTTAAGTGAGTCAGGTGTGCTTTTTATTTCCCTTGTTTCTCATTTTGCCCTGTCAGTGGATGGTAGA 2161 TGCTTTGTATATCTTAAATCCCTTAAAGGATCTTAAAGACATCCCTCAGGTGTTCTATTTAACTTTTATTTTATTTTATT 2241 TTATTTATTTATTTATTTTGAGACTGAGTCTTGCTCTGTCGCCCAGGCTGGAGTGCAGTGGCATGATCTCGGCTCACTGC 2321 AACTTCTGCCTCCCAGGTTCAAGCCATTCTCCTGCCTCGGCCTCCTGAGTAGCTGGGATTACAGTTGCCGCCACACCCGG 2401 CTTATTTTTTTGTATTTTTAGTAGAGGCAGAGTTTCACCATGTTGGCCAGGCTAGTCTCGAACTCCTGACCTCAGATGAT 2481 CCGCCCACATTGGCCTCCCAAAGTGCTGGGATTACAGGTGTGATCCACCGCACCTGGCCCTAACTTTTAATATACAACAC 2561 ACACACACACACACACACACACACACACACACACACACACACACACACACACACTATTTCAGAAGACAGTGTGTTGCCTT 2641 ACCCAGAATGAGTGCTAGGATTACAGGCGTGAGACAGACACACATACACACACATACACACACACAGAGTCTTTATTGCA 2721 GAAGACAGTGTGTTGCCTTATAGGCGTGAGACACACACACACACACACACACACACACACACACACACAGTCTTTATTGC 2801 AGAAGACAGTGTGTTGCCTTACCAGAATGAGTGCTTGGATTACAGGCGTGAGCCACTGTGCCCAGCCCTAACTTTTAATG 2881 TACATCACACACACACTCACACTCACATACACACACACACACACACTCTGACTGTCTTTATTGCAGAAGACAGTGTGTTG 2961 CCTTACCCAGAATGAGATTGAATTGTTTTGCTTCGTTTTGTTTTGTTATTCAGTGTTGCGGTAGCAGATGCATTATCAAA 3041 GGAAAAATATTTGGCTCCTTTAATTCCTCTGAAAACATGAGTATTTTGAGTTCTGCAGCACAATGACTGTAGGACTAAGC 3121 TAAGTCTGCTTTGCAGATATCTGATCAGATAGTCCCTTCATTCTGTAGACGTGTATTGGTTGGTCCAAGACACAGTGAGT 3201 AGGAGCTCTGTGGACCAAGACAAAGCTGGACTAGAGAGTACAGTTCAAACTTGGCAGTTTCTCTAACGACTCTGTATAGC 3281 TTCTGGCTTCTACTACTGAAACAAGAGTTTAGATCACTGATGGAGAGGCATAGTAATCTGTTTGTGCTTTGGAAAAATAT 3361 ATAAAAGTTTTTTTCCCCTATTTTTTGCACTTTAAATCTGTTTTGAAATTAGAACTGATATACATTTATTTGAATAATGT 3441 GTAACTATTATGGATCTATTTTAATGAACAATTTTTACCATTTCCCAAGCTGCCTGTTTATTATAAGCATGACATGTTTA 3521 CTATAAACCTTTTGCCCCCATAATTTCTTTTTTTAAAGGAAATTAATATTAGTAAAATAAACACCTCTTTAATGGAAGCT 3601 GCAACCTTCTAGTGATCCAAGTAGACAATAGATGGTGGCATCACAGACTTTATCTACACACTTTCGGGTCTGACCACTAC 3681 CTCCCACAATACCTAGCCATTTTGGAAGGGGAAAACATGCGGTGGTCTAGCTGTATAGCTCAGGGCTTAATTTCAGCTTC 3761 TGAGATTGTGATGTCATATTTCACTCTCAAAACATAGGCTGAAAGCACGAATTACTCAAAAAGTAAGCAAACCAATACCT 3841 GGTGAATCTATGGACAGTCATACACATACATCAGGGGAAAATGTGTGTGTACAACCCAAATTTACAGTATGATTGTCATT 3921 CTTTGACTTTGTTTTGTATAGCCTGACTCTGTTGAACATGAAATTATTAGTACTCTAGGTTTTGGACAGCTTGAGTTCAT 4001 TTGAATTCCTTCCTTAGGAATAAGTTTTTATATACACTGCTAAATGTGTGATGAGAATCATAAAACACTAACCAGCTGAG 4081 GTAGCTGTGATTCACTTTCCCCCCACCCTAACTTGAGATAAAATGAAGGACTAGGCAAGTATTTCATGTTGTGTGAGTGG 4161 ACTTCGGTTCCTTCAGTATTGTCTAGGTTATTGAGTCTTTCTTTGCCTAATAGTGGATTCCCACTCTTAAGATAACTTTT 4241 ATTAGTGATAAATCAGTTTAGGGTATATTCTGTATGACAGGCATAAAATGTTAAGGGTGAATGCTGGCCTTTTCCAAGAA 4321 AAGGCCACCTTAACTTGTATGAGGAAAAAATCCTAACTATTCTCTTTTTTGTATCTTTTTTTCCGTAACTGTTTTGATTG 4401 TATATTTTAAAGAAACCACTTAATTTGTGATGCACGTAATATTTGTGTGAACCTGAGAATATGTCACAATAGGAAAAAGC 4481 AGAAATTATACTTAGGGGACATGTTAGGGGGGTAAAAATATTTAAGCCTCGAATGTTTTACTGTCATCTCCACTAACTAT 4561 TTTTACAGAAAAAGCTAAAAACTCTGTTGTAATTATTGTAAGTTTACTTATTTATACTTTTAAATTAGGCTTTTCATACT 4641 TAAATTTTTTTGACATTTGCTTTTAATATTTGTTTCTTAATGTGGAAATTGTGTATTTTAATAATCAAATTATTAGGATA 4721 ATAGATATATTTTTAAACATTCACCTCATTAACAAATAGATCTTTGAATTTTTATTAGGTTTTTTGGCTCCAGACAACTG 4801 TTTAGCTTTAATGATATTTCTAAATTCCCAGTGACTTATTAATAAAAACAGGAAAAATATTTAGGTAATGTCATAAAATT 4881 TATTTTACCTTTCTCATTTTCTGAGAAAATAAATGAAAAAAACCCTAGATATTGCTTTATTACCAACAGTGTGTAGGTTT 4961 TTGTACATATGGAAATTTGACACAAAAAAATAGGGAATTTGTATAGAGAAGTTTCCCTCTTATAAAAGGACTCCCATTTG 5041 ATTGTTCGAAACTATAAAATGCACTTTTACTTTACCATATCTGAAATGACAAAATATCGCCCTTTGGAAAACCTGACTCT 5121 TTGCACGTGTAATTCCCAGAGTCTACCTCAGTTAACCAGGCTTAGTTTTAGGCAGGAATGAATTGAATTAAATTCAGTTC 5201 ATCATCTATGCAGATTTGTTTCTTTTAAGCACATCCTTCCCTCCTGCTGTTGCCCTCCTCCCATTAACTTTTCTTTTTAA 5281 TCTTGAAATTGTTTAAAATATTCCATCTTTCTTTCTCTAGCAAAGTGTTTGTATTCCAAATAAGGCCTCTGTGAAATGTC 5361 TGAATTACTTTTCCCGTCTTTGTTATGGTCAGCTTCATTATTTGGATGTATTGCATTCAAAGCAGCAGTTCCAAACATAA 5441 CACACATCTATTTTCTTAGAGTTTTGTAAATACAAACTAACCTGATGACATTAAAAATTGTGGATCCTACATGTTCCTAT 5521 GTTCATTCTCTAAAAACCTGAGTAACTTTATGAAAACACACAAACCTGGAAAAACATCACATTTTTGTCACATTTTTACT 5601 GACAAATGTATATTCATATGATGGTACGGCAGCAGGGAGTGGCCCCCAGTTAACATGGCTGTGAGTGGACACAGTGTCTC 5681 GCAGGATCACTGCATGTTATGATGGCTTGTAAGTGCGTTGTTAAGACTTTTGTTTCAGTGTTTGTCTCCCAGTATTTGAA 5761 CCTAATTTAAAGAAAAAGACGTTTCCAAGTTGTATTTATTAAATGTGTTTTTCCTTACCTTTTGTGCTGCTACTTTGCTA 5841 ATCTCATTAGCTTAGCTGTGTTTGTGCATAGGTTATATTTGGTAATAAATTTATAGAGTGTTGGTTGTCA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-1 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796038. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796038 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000380615.3 | 3UTR | UCAAGCUUUUAAAAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
107 hsa-miR-100-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT105690 | LEPROTL1 | leptin receptor overlapping transcript like 1 | 2 | 2 | ||||||||
MIRT151558 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | 2 | 4 | ||||||||
MIRT167753 | SGK1 | serum/glucocorticoid regulated kinase 1 | 2 | 2 | ||||||||
MIRT195380 | CBFB | core-binding factor beta subunit | 2 | 2 | ||||||||
MIRT283995 | DNAJA2 | DnaJ heat shock protein family (Hsp40) member A2 | 2 | 2 | ||||||||
MIRT317145 | E2F3 | E2F transcription factor 3 | 2 | 4 | ||||||||
MIRT380785 | ZFP3 | ZFP3 zinc finger protein | 2 | 2 | ||||||||
MIRT380927 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT441600 | ABCB5 | ATP binding cassette subfamily B member 5 | 2 | 6 | ||||||||
MIRT443896 | NUDT3 | nudix hydrolase 3 | 2 | 4 | ||||||||
MIRT444030 | GREM1 | gremlin 1, DAN family BMP antagonist | 2 | 4 | ||||||||
MIRT444112 | CEPT1 | choline/ethanolamine phosphotransferase 1 | 2 | 2 | ||||||||
MIRT444169 | ZNF701 | zinc finger protein 701 | 2 | 2 | ||||||||
MIRT444366 | TIMM8B | translocase of inner mitochondrial membrane 8 homolog B | 2 | 2 | ||||||||
MIRT444371 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT444517 | ZNF525 | zinc finger protein 525 | 2 | 2 | ||||||||
MIRT444525 | CNIH4 | cornichon family AMPA receptor auxiliary protein 4 | 2 | 2 | ||||||||
MIRT444529 | EIF2A | eukaryotic translation initiation factor 2A | 2 | 2 | ||||||||
MIRT444537 | PHKB | phosphorylase kinase regulatory subunit beta | 2 | 2 | ||||||||
MIRT444702 | GATSL2 | cytosolic arginine sensor for mTORC1 subunit 2 | 2 | 2 | ||||||||
MIRT444717 | CMSS1 | cms1 ribosomal small subunit homolog (yeast) | 2 | 2 | ||||||||
MIRT444730 | TMC7 | transmembrane channel like 7 | 2 | 2 | ||||||||
MIRT444777 | NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | 2 | 2 | ||||||||
MIRT444802 | TMEM251 | transmembrane protein 251 | 2 | 2 | ||||||||
MIRT444995 | LRRC57 | leucine rich repeat containing 57 | 2 | 2 | ||||||||
MIRT445073 | C16orf87 | chromosome 16 open reading frame 87 | 2 | 2 | ||||||||
MIRT445250 | SEMA5A | semaphorin 5A | 2 | 2 | ||||||||
MIRT445336 | KATNAL1 | katanin catalytic subunit A1 like 1 | 2 | 2 | ||||||||
MIRT445426 | TPT1 | tumor protein, translationally-controlled 1 | 2 | 4 | ||||||||
MIRT445469 | TRIM13 | tripartite motif containing 13 | 2 | 2 | ||||||||
MIRT445646 | NPY4R | neuropeptide Y receptor Y4 | 2 | 2 | ||||||||
MIRT445759 | AGO1 | argonaute 1, RISC catalytic component | 2 | 2 | ||||||||
MIRT445838 | SRSF11 | serine and arginine rich splicing factor 11 | 2 | 2 | ||||||||
MIRT445868 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT446368 | STX16 | syntaxin 16 | 2 | 2 | ||||||||
MIRT446444 | THYN1 | thymocyte nuclear protein 1 | 2 | 2 | ||||||||
MIRT446593 | TASP1 | taspase 1 | 2 | 2 | ||||||||
MIRT446926 | SRSF7 | serine and arginine rich splicing factor 7 | 2 | 2 | ||||||||
MIRT447121 | SLFN5 | schlafen family member 5 | 2 | 2 | ||||||||
MIRT447196 | CDCP1 | CUB domain containing protein 1 | 2 | 2 | ||||||||
MIRT447358 | STOM | stomatin | 2 | 2 | ||||||||
MIRT447361 | FAM161B | family with sequence similarity 161 member B | 2 | 2 | ||||||||
MIRT447374 | NUP205 | nucleoporin 205 | 2 | 2 | ||||||||
MIRT447467 | OSMR | oncostatin M receptor | 2 | 2 | ||||||||
MIRT447606 | MRPL3 | mitochondrial ribosomal protein L3 | 2 | 2 | ||||||||
MIRT447682 | ASPA | aspartoacylase | 2 | 2 | ||||||||
MIRT447715 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT447814 | EMX1 | empty spiracles homeobox 1 | 2 | 2 | ||||||||
MIRT447855 | RRP8 | ribosomal RNA processing 8 | 2 | 4 | ||||||||
MIRT447866 | KIAA1244 | ARFGEF family member 3 | 1 | 1 | ||||||||
MIRT447890 | STRIP2 | striatin interacting protein 2 | 2 | 2 | ||||||||
MIRT447916 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 2 | 2 | ||||||||
MIRT447935 | DUSP4 | dual specificity phosphatase 4 | 2 | 2 | ||||||||
MIRT448813 | GABRB1 | gamma-aminobutyric acid type A receptor beta1 subunit | 2 | 2 | ||||||||
MIRT448927 | CKS1B | CDC28 protein kinase regulatory subunit 1B | 2 | 2 | ||||||||
MIRT449105 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT449216 | ZNHIT3 | zinc finger HIT-type containing 3 | 2 | 2 | ||||||||
MIRT449336 | ACTBL2 | actin, beta like 2 | 2 | 2 | ||||||||
MIRT449675 | SOX3 | SRY-box 3 | 2 | 2 | ||||||||
MIRT449724 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT449768 | PRAMEF7 | PRAME family member 7 | 2 | 2 | ||||||||
MIRT449804 | PRAMEF8 | PRAME family member 8 | 2 | 2 | ||||||||
MIRT449850 | BCL2L13 | BCL2 like 13 | 2 | 2 | ||||||||
MIRT449866 | POFUT2 | protein O-fucosyltransferase 2 | 2 | 2 | ||||||||
MIRT450067 | SYT9 | synaptotagmin 9 | 2 | 2 | ||||||||
MIRT450197 | ZHX3 | zinc fingers and homeoboxes 3 | 2 | 2 | ||||||||
MIRT450386 | TENM4 | teneurin transmembrane protein 4 | 2 | 2 | ||||||||
MIRT450435 | PAX8 | paired box 8 | 2 | 2 | ||||||||
MIRT450716 | PVRL3 | nectin cell adhesion molecule 3 | 2 | 2 | ||||||||
MIRT495906 | PGM2L1 | phosphoglucomutase 2 like 1 | 2 | 2 | ||||||||
MIRT497543 | PPTC7 | PTC7 protein phosphatase homolog | 2 | 2 | ||||||||
MIRT497630 | ZNF576 | zinc finger protein 576 | 2 | 2 | ||||||||
MIRT497756 | OXGR1 | oxoglutarate receptor 1 | 2 | 2 | ||||||||
MIRT498072 | SLC25A12 | solute carrier family 25 member 12 | 2 | 2 | ||||||||
MIRT500542 | XPO4 | exportin 4 | 2 | 4 | ||||||||
MIRT500848 | SYPL1 | synaptophysin like 1 | 2 | 4 | ||||||||
MIRT511621 | HIST1H3J | histone cluster 1 H3 family member j | 2 | 4 | ||||||||
MIRT513745 | PKNOX1 | PBX/knotted 1 homeobox 1 | 2 | 2 | ||||||||
MIRT535077 | PPP1CB | protein phosphatase 1 catalytic subunit beta | 2 | 2 | ||||||||
MIRT543133 | ZFP36L1 | ZFP36 ring finger protein like 1 | 2 | 2 | ||||||||
MIRT544518 | GTF2E2 | general transcription factor IIE subunit 2 | 2 | 2 | ||||||||
MIRT544666 | MED19 | mediator complex subunit 19 | 2 | 2 | ||||||||
MIRT545407 | KIAA1715 | lunapark, ER junction formation factor | 2 | 2 | ||||||||
MIRT547569 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 4 | ||||||||
MIRT548767 | CNN3 | calponin 3 | 2 | 2 | ||||||||
MIRT551009 | TRIM4 | tripartite motif containing 4 | 2 | 2 | ||||||||
MIRT555077 | PURG | purine rich element binding protein G | 2 | 2 | ||||||||
MIRT560753 | ZNF616 | zinc finger protein 616 | 2 | 2 | ||||||||
MIRT563752 | FOXO3 | forkhead box O3 | 2 | 2 | ||||||||
MIRT565531 | SON | SON DNA binding protein | 2 | 2 | ||||||||
MIRT613933 | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | 2 | 2 | ||||||||
MIRT614433 | TAZ | tafazzin | 2 | 2 | ||||||||
MIRT622520 | RAP2A | RAP2A, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT626037 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT648459 | LEAP2 | liver enriched antimicrobial peptide 2 | 2 | 2 | ||||||||
MIRT654982 | PLCXD3 | phosphatidylinositol specific phospholipase C X domain containing 3 | 2 | 4 | ||||||||
MIRT689103 | ZBTB25 | zinc finger and BTB domain containing 25 | 2 | 2 | ||||||||
MIRT704259 | DHCR24 | 24-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT711194 | CXCL3 | C-X-C motif chemokine ligand 3 | 2 | 2 | ||||||||
MIRT713315 | VLDLR | very low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT717266 | BMPR2 | bone morphogenetic protein receptor type 2 | 4 | 2 | ||||||||
MIRT718248 | CCDC18 | coiled-coil domain containing 18 | 2 | 2 | ||||||||
MIRT721944 | NGRN | neugrin, neurite outgrowth associated | 2 | 2 | ||||||||
MIRT721948 | IL1RAPL1 | interleukin 1 receptor accessory protein like 1 | 2 | 2 | ||||||||
MIRT734969 | PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 | 3 | 0 | ||||||||
MIRT735945 | NME2 | NME/NM23 nucleoside diphosphate kinase 2 | 0 | 0 | ||||||||
MIRT737404 | HOXA1 | homeobox A1 | 4 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|